Included in the formulation
АТХ:S.01.A.X.16 Pycloxidine
Pharmacodynamics:The drug has antiseptic and bactericidal action against Staphylococcus aureus, Streptococcus faecalis, Escherichia coli, Eberthella typhosa, Klebsiella pneumoniae, Proteus vulgaris, Shigella dysenteria, Bacillus subtilis, Chlamydia trachomatis; some viruses and fungi.
Pharmacokinetics:With topical application, systemic absorption is low.
Indications:Infectious-inflammatory diseases of the eyes (conjunctivitis, keratoconjunctivitis).
I.A70-A74.A74.0 Chlamydial conjunctivitis (H13.1 *)
VII.H15-H22.H16.2 Keratoconjunctivitis
VII.H10-H13.H10.4 Chronic conjunctivitis
VII.H10-H13.H10.2 Other acute conjunctivitis
Contraindications:Individual intolerance.
Pregnancy and lactation:The category of FDA recommendations is not defined. Adequate and well-controlled studies in humans and animals have not been conducted. There is no information on the penetration into breast milk.
Dosing and Administration:Bury one drop every 2-6 times a day in a conjunctival sac. The course of treatment is ten days.
Side effects:Irritation of the conjunctiva, allergic reactions.
Overdose:Not described. Treatment is symptomatic.
Interaction:Other eye drops should be instilled with an interval of at least 15 minutes.
Special instructions:In case of loss of clarity of visual perception during the application of drops within 30 minutes after the next instillation, it is not recommended to engage in potentially dangerous activities requiring increased attention and rapid psychomotor reactions.